Patients Treated at the Neurosurgery DepartmentpatregNCHNCT01628406
Patient Registry of the Neurosurgery Department
An observational study of Patients Treated at the Neurosurgery Department, run by University of Zurich at 1 site in Switzerland.
Trial summary
The investigators record all indications, treatments and outcomes from patients treated at the Neurosurgery Department. Trial with surgical intervention Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Patients Treated at the Neurosurgery Department
- What is being tested?
- Treatment at the neurosurgery departement
- Type of treatment
- Surgery or procedure
- How many people
- 24,000 participants
- Where
- 1 siteSwitzerland
- Study dates
- Jun 2012to Dec 2032
- How long will I take part?
- 10 Years
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: All patients treated at the Neurosurgery Department
Who may be able to join
- All patients treated at the Neurosurgery Department
Who cannot join
- None
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Switzerland1 site
University Hospital Zurich, Neurosurgery
Zurich, Canton of Zurich, 8091
About this study
Official title: Patient Registry of the Neurosurgery Department.
The investigators record all indications, treatments and outcomes from patients treated at the Neurosurgery Department.
- Trial with surgical intervention
- Being tested
- Treatment at the neurosurgery departement
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Treatment at the neurosurgery departementProcedure or surgery
Treatment at the neurosurgery departement
| Study group | Role | What they receive |
|---|---|---|
| Patients treated at the neurosurgery department | Patients treated at the neurosurgery department Receives: Procedure: Treatment at the neurosurgery departement |
What is being measured
The primary outcome is the main question the study is designed to answer.
neurological outcome
validated scales like KPSS or NIHSS
Measured: 1 year
social outcome
e.g. activity of daily living, employment status
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jun 2012 (estimated)
- Study startJun 2012
- Primary completionDec 2032 (estimated)
- Study completionDec 2032 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Patients Treated at the Neurosurgery DepartmentStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 24,000 participants (estimated)
- Target duration
- 10 Years
Sponsor and investigators
- Lead sponsor
- University of Zurich
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Johannes Sarnthein, Prof Dr, Principal investigator, University Hospital Zurich, Division of NeurosurgeryLuca Regli, Prof Dr, Principal investigator, University Hospital Zurich, Division of Neurosurgery
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01628406
- Sponsor's protocol ID
- patregNCH
- Acronym
- patregNCH
- Status last verified
- Jan 2026
- First submitted
- 21 Jun 2012
- Last updated
- 23 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Sarnthein J, Staartjes VE, Regli L; Neurosurgery-Registry consortium. Neurosurgery outcomes and complications in a monocentric 7-year patient registry. Brain Spine. 2022 Jan 19;2:100860. doi: 10.1016/j.bas.2022.100860. eCollection 2022.
PubMed 36248111To J, Muller T, Bozinov O, Regli L, Krayenbuhl N, Velz J. Intraoperative MRI in pediatric brain tumor surgery: Optimizing surgical decision-making and extent of resection. Childs Nerv Syst. 2026 Sep 17;42(1):367. doi: 10.1007/s00381-026-07456-w.
PubMed 42749835Staartjes VE, Serra C, Regli L. In Reply: Safety and Effectiveness of an Enhanced Recovery Protocol in Patients Undergoing Burr Hole Evacuation for Chronic Subdural Hematoma. Neurosurgery. 2025 Jan 1;96(1):e16-e17. doi: 10.1227/neu.0000000000003235. Epub 2024 Oct 24. No abstract available.
PubMed 39445855Sebok M, Hobner LM, Grob A, Fierstra J, Schubert T, Wegener S, Luft AR, Kulcsar Z, Regli L, Esposito G. Flow capacity of a superficial temporal artery as a donor in a consecutive series of 100 patients with superficial temporal artery-middle cerebral artery bypass. J Neurosurg. 2024 Aug 9;142(1):62-69. doi: 10.3171/2024.4.JNS24247. Print 2025 Jan 1.
PubMed 39126722